ABOUT US

A biotechnological company which mission is to generate robust clinical therapeutic candidates available for development and commercialization partnerships with pharmaceutical companies.


PIPELINE

DIGNA has several products in clinical and preclinical development focused mainly in critical care therapies and centered on indications targeted by orphan-designated drugs”.


PARTNERING

DIGNA leverages world-class scientific and clinical expertise to push medical innovations through early clinical development, reduce financial risk, and thereby increase their partnering appeal to suitable drug developers.